Antivenom therapy of carpet viper (Echis ocellatus) envenoming: Effectiveness and strategies for delivery in West Africa

Toxicon

Volumn 69, Issue , 2013, Pages 82-89

  Habib, Abdulrazaq G ^a   Warrell, David A ^b  

^a BAYERO UNIVERSITY   (Nigeria)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antivenom; Carpet viper; Echis ocellatus; Effectiveness; Mortality; West Africa

Indexed keywords

SNAKE VENOM; SNAKE VENOM ANTISERUM; VENOM ANTISERUM; VIPER VENOM; ANTIGEN; UNCLASSIFIED DRUG; VENOM ANTIGEN;

AFRICA; ARTICLE; BLEEDING; BLOOD CLOTTING; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ECHIS OCELLATUS; ENDEMIC DISEASE; ENVENOMATION; HEALTH CARE ACCESS; HEALTH CARE MANPOWER; HEALTH CARE QUALITY; HUMAN; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK FACTOR; RURAL AREA; STANDARDIZATION; WEST AFRICA; ANIMAL; BLOOD COAGULATION DISORDERS; DRUG EFFECTS; DRUG SCREENING; META ANALYSIS; SNAKE BITES; TOXICITY; VIPERIDAE; AFRICA SOUTH OF THE SAHARA; ASIA; COMPARATIVE STUDY; FEASIBILITY STUDY; GEOGRAPHY; HEALTH CARE DELIVERY; MANPOWER; META ANALYSIS (TOPIC); SNAKEBITE; BLOOD CLOTTING DISORDER; DRUG EFFECT; REVIEW;

ECHIS CARINATUS; ECHIS OCELLATUS; ECHIS PYRAMIDUM; SERPENTES;

AFRICA, WESTERN; ANIMALS; ANTIVENINS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; DRUG EVALUATION, PRECLINICAL; HUMANS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SNAKE BITES; VIPER VENOMS; VIPERIDAE;

EID: 84878488250     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2013.01.002     Document Type: Article

References (35)

1. Abubakar S.B., Abubakar I.S., Habib A.G., Nasidi A., Durfa N., Yusuf P.O., Larnyang S., Garnvwa J., Sokomba E., Salako L., Laing G.D., Theakston R.D., Juszczak E., Alder N., Warrell D.A., Nigeria-UK EchiTab Study Group Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria. Toxicon 2010, 55(4):719-723.
2. Abubakar I.S., Abubakar S.B., Habib A.G., Nasidi A., Durfa N., Yusuf P.O., Larnyang S., Garnvwa J., Sokomba E., Salako L., Theakston R.D., Juszczak E., Alder N., Warrell D.A., Nigeria-UK EchiTab Study Group Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria. PLoS Negl Trop. Dis. 2010, 4(7):e767.
3. Balde M.C., Chippaux J.-P., Boiro M.Y., Stock R., Massougbodji A. Clinical study of tolerance and effectiveness of a F(ab')2 polyvalent antivenom for African snake bites in Kindia, Guinea. Bull. Soc. Pathol. Exot. 2012, 10.1007/s13149-012-0223-3.
4. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
5. Begg C.B., Pilote L. A model for incorporating historical controls into a meta-analysis. Biometrics 1991, 47(3):899-906.
6. Bregani E.R., Cantoni F., Tantardini F. Snake bites in South Chad. Comparison between three different polyvalent anti-snake venom immunotherapies. Ital. J. Trop. Med. 2006, 11(1-2):25-28.
7. Brown S.G., Caruso N., Borland M.L., McCoubrie D.L., Celenza A., Isbister G.K. Clotting factor replacement and recovery from snake venom-induced consumptive coagulopathy. Intensive Care Med. 2009, 35(9):1532-1538.
8. Calvete J.J., Cid P., Sanz L., Segura A., Villalta M., Herrera M., Leon G., Harrison R., Durfa N., Nasidi A., Theakston R.D.G., Warrell D.A., Gutierrez J.M. Antivenomic assessment of the immunologic reactivity of the EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in Sub-Saharan Africa. Am. J. Trop. Med. Hyg. 2010, 82(6):1194-1201.
9. Casewell N.R., Cook D.A., Wagstaff S.C., Nasidi A., Durfa N., Wüster W., Harrison R.A. Preclinical assays predict pan-African Echis viper efficacy for a specie-specific antivenom. PLoS Negl Trop. Dis. 2010, 4(10):e851.
10. Chippaux J.P., Massougbodji A., Stock R.P., Alagon A. Investigators of African Antivipmyn in Benin. Clinical trial of an F(ab')2 polyvalent equine antivenom for African snake bites in Benin. Am. J. Trop. Med. Hyg. 2007, 77:538-546.
11. Chippaux J.P., Lang J., Amadi Eddine S., Fagot P., Rage V., Peyrieux J.C., Le Mener V., et al. Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. Trans. Roy Soc. Trop. Med. Hyg. 1998, 92:657-662.
12. Chippaux J.P., Lang J., Amadi Eddine S., Fagot P., Le Mener V. Treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F(ab')2: results of a clinical trial in northern Cameroon. Am. J. Trop. Med. Hyg. 1999, 61:1017-1018.
13. Daudu I., Theakston R.D.G. Preliminary trial of a new polyspecific antivenom in Nigeria. Ann. Trop. Med. Parasitol. 1988, 82(313):311-313.
14. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin. Trial. 1986, 7(3):177-188.
15. Habib A.G., Abubakar S.B. Factors affecting snakebite mortality in north-eastern Nigeria. Int. Health 2011, 3:50-55.
16. Isbister G.K. Antivenom efficacy or effectiveness: the Australian experience. Toxicology 2010, 268(3):148-154.
17. Isbister G.K., Duffull S.B., Brown S.G. Failure of antivenom to improve recovery in Australian snakebite coagulopathy. Q. J. Med. 2009, 102(8):563-568.
18. Isbister G.K. Procoagulant snake toxins: laboratory studies, diagnosis, and understanding snakebite coagulopathy. Semin. Thromb. Hemost. 2009, 35(1):93-103.
19. Kini R.M. The intriguing world of prothrombin activators from snake venom. Toxicon 2005, 45:1133-1145.
20. Meyer W.P., Habib A.G., Onayade A.A., et al. First clinical experience with a new ovine Fab Echis ocellatus snake bites antivenom in Nigeria. Randomized comparative trial with institute Pasteur Serum (IPSer) Africa antivenom. Amer. J. Trop. Med. Hyg. 1997, 56(3):292-300.
21. Mohapatra B., Warrell D.A., Suraweera W., Bhatia P., Dhingra N., Jotkar R.M., Rodriguez P.S., Mishra K., Whitaker R., Jha P. Snakebite mortality in India: a nationally representative mortality survey. PLoS Negl. Trop. Dis. 2011, 5(4):e1018. Million Death Study Collaborators.
22. Paksima N., Panchal A., Posner M.A., Green S.M., Mehlman C.T., Hiebert R. A meta-analysis of the literature on distal radius fractures: review of 615 articles. Bull. Hosp. Jt. Dis. 2004, 62(1&2):40-46.
23. Petras D., Sanz L., Segura A., Herrera M., Villalta M., Solano D., Vargas M., León G., Warrell D.A., Theakston R.D., Harrison R.A., Durfa N., Nasidi A., Gutiérrez J.M., Calvete J.J. Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches. J. Proteome Res. 2011, 10(3):1266-1280.
24. Pugh R.N., Theakston R.D.G. A clinical study of viper bite poisoning. Ann. Trop. Med. Parasitol. 1987, 81(2):135-149.
25. Ramos-Cerrillo B., de Roodt A.R., Chippaux J.-P., Olguin L.R., Casasola A., Guzman G., Paniagua-Solis J., Alagon A., Stock R.P. Characterization of a new polyvalent antivenom (Antivipmyn-Africa) against African vipers and elapids. Toxicon 2008, 52:881-888.
26. Segura A., Villalta M., Herrera M., León G., Harrison R., Durfa N., Nasidi A., Calvete J.J., Theakston R.D., Warrell D.A., Gutiérrez J.M. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa. Toxicon 2010, 55(2-3):369-374. Epub 2009 Aug 21.
27. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. J. Am. Med. Assoc. 2000, 283:2008-2012.
28. Tanos, P.P., Isbister, G.K., Lalloo, D.G., Kirkpatrick, C.M., Duffull, S.B., 2008. A model for venom-induced consumptive coagulopathy in snake bite. 52(7), 769-780.
29. Visser L.E., Kyei-Faried S., Belcher D.W., et al. Protocol and monitoring to improve snake bite outcomes in rural Ghana. Trans. R. Soc. Trop. Med. Hyg. 2004, 98:278-283.
30. Visser L.E., Kyei-Faried S., Belcher D.W., Geelhoed D.W., van Leeuwen J.S., van Roosmalen J. Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance. Trans. R Soc. Trop. Med. Hyg. 2008, 102(5):445-450.
31. Warrell D.A., Arnett C. The Importance of Bites by the Saw-Scaled or Carpet Viper (Echis carinatus). Epidemiological Studies in Nigeria and a Review of World Literature Acta Tropica 1976, vol. 33. pp. 307-341.
32. Warrell D.A., Davidson N.Mc.D., Greenwood B.M., et al. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Quart. J. Med. (ns) 1977, 46:33-62.
33. Warrell D.A., Davidson N.M., Omerod L.D., Pope H.M., Watkins B.J., Greenwood B.M., Ried H.A. Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms. Br. Med. J. 1974, 4(5942):437-440.
34. Warrell D.A., Warrell M.J., Edgar W., Prentice C.R., Mathison J., Mathison J. Comparison of Pasteur and Behringwerke antivenoms in envenoming by the carpet viper (Echis carinatus). Br. Med. J. 1980, 280(6214):607-609.
35. Warrell D.A. Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product-'what's in a name?'. Trans. R Soc. Trop. Med. Hyg. 2008, 102(5):397-399.